Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-25 @ 9:48 PM
NCT ID:
NCT02775851
Group ID:
EG000
Title:
Cohort A: MK-3475 (Pembrolizumab)
Description:
Resectable patients receive pembrolizumab IV over 30 minutes on day 1. Treatment repeats every 21 days for up to 3 cycles. Patients with potentially resectable disease undergo surgery. Patients with tumor progression and unresectable disease may receive one additional cycle of pembrolizumab.
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
1
Serious Number At Risk:
29
Other Number Affected:
23
Other Number At Risk:
29
Study:
NCT02775851
Results Section:
NCT02775851
Adverse Events Module:
NCT02775851